PureCycle Technologies (PCT) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
16 Mar, 2026Executive summary
Solicitation seeks consent from warrant holders to amend the Warrant Agreement, lowering the Redemption Trigger Price from $18.00 to $14.38 per share and extending the expiration date of all PCT Warrants to March 17, 2027, if approved.
The Board unanimously recommends approval, citing increased likelihood for warrant holders to realize value and for the company to receive proceeds from warrant exercises.
If the amendment is not approved, the Redemption Trigger Price remains at $18.00 and warrants expire on June 17, 2026.
The company will bear all solicitation costs, including a $7,500 fee to Mediant for communication assistance.
Voting matters and shareholder proposals
The proposal requires written consent from holders of a majority of outstanding PCT Warrants as of March 17, 2026.
Shareholders may consent, object, or abstain via mail, email, or Internet; abstentions and non-responses count as votes against.
No shareholder proposals or director nominations were received for the 2026 annual meeting.
Board of directors and corporate governance
The Board unanimously approved the Warrant Amendment on March 5, 2026, and recommends warrant holders consent to the proposal.
Board members and executive officers collectively own 18.8% of outstanding common stock as of March 12, 2026.
Latest events from PureCycle Technologies
- Record production, new funding, and strong trials set stage for growth despite ongoing losses.PCT
Q3 20249 Jul 2026 - Operational and commercial milestones, funding, and strong demand drive growth outlook.PCT
Q4 20248 Jul 2026 - First $1.6M revenue, 90% uptime, BOPP breakthroughs, and $59M+ capital raised in Q1 2025.PCT
Q1 20258 Jul 2026 - Record production and revenue growth, with robust liquidity and strong commercial momentum.PCT
Q1 20267 May 2026 - Virtual meeting to elect nine directors, ratify auditor, and approve executive pay.PCT
Proxy filing27 Mar 2026 - Annual meeting covers director elections, auditor ratification, executive pay, global growth, and ESG milestones.PCT
Proxy filing27 Mar 2026 - Proposal seeks to lower the warrant Redemption Trigger Price and extend expiration to 2027.PCT
Proxy filing26 Mar 2026 - Gen 2 technology and regulatory shifts position the company for rapid growth and global expansion.PCT
The 38th Annual Roth Conference23 Mar 2026 - Record Q4 production and $2.7M revenue growth set the stage for global expansion in 2026.PCT
Q4 202527 Feb 2026